Fibrinolytic Therapy in Clinical Practice Publisher:Informa Healthcare Pages:256 2003-07-31 ISBN: 1841840815 PDF 2.7 MBOne of the major breakthroughs in the treatment of cardiovascular disease is the introduction of fibrinolytic therapy. Better knowledge of the pathogenesis of acute ischemic syndromes has identified acute thrombosis as the triggering event in most cases. Thrombosis of large and small arteries may have catastrophic consequences as sudden death, myocardial infarction, ischemic stroke, pulmonary embolism and acute limb necrosis. Fibrinolytic therapy is aimed at early restoration of occluded blood vessels, thus improving symptoms and organ recovery, reducing infarct size and improving quantity and quality of life. However, fibrinolytic drugs have severe, sometimes fatal side-effects. These center on bleeding, sometimes fatal cerebral bleeding. Therefore, stringent patient selection is mandatory; age, time to treatment, relative and absolute contraindications and comitant medication are of utmost importance for safe and efficacious fibrinolysis.
http://uploaded.to/?id=5gnghk
http://uploaded.to/?id=5gnghk
No comments:
Post a Comment